Menchavez, Paulina A.
HRN: 26-61-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
FLUCONAZOLE 50MG (CAP)
02/08/2025
02/15/2025
PO
50 Mg/cap
OD
CAP-MR; With Yeast Infection
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes